ConductScience.org, home

Paper40469640

Long-term outcomes of a case-control lung transplant cohort after SARS-CoV-2 infection.

Hanna S and 8 others. Front Transplant, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Long-term outcomes of a case-control lung transplant cohort after SARS-CoV-2 infection. Papers, record 40469640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40469640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term outcomes of a case-control lung transplant cohort after SARS-CoV-2 infection.
PubMed
Journal
Front Transplant
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-06-07
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hanna SSandrine
2Hallak RRami
3Leonard SMSusanna M
4Morrison SSamantha
5Peskoe SSarah
6Whitson JJordan
7Reynolds JMJohn M
8Wolfe CRCameron R
9Ali HAHakim Azfar

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19001326Spirometry values in stable lung transplant recipients.Am J Respir Crit Care Med1997https://conductscience.org/library/papers/9001326PubMed
220524853Upper and lower respiratory tract viral infections and acute graft rejection in lung transplant recipients.Clin Infect Dis2010https://conductscience.org/library/papers/20524853PubMed
333352869Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.Cancers (Basel)2020https://conductscience.org/library/papers/33352869PubMed
427467538Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.Transplantation2016https://conductscience.org/library/papers/27467538PubMed
526565010Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.Clin Infect Dis2016https://conductscience.org/library/papers/26565010PubMed
633246166COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.Transplant Rev (Orlando)2021https://conductscience.org/library/papers/33246166PubMed
733811777COVID-19 in solid organ transplant recipients: A national cohort study from Sweden.Am J Transplant2021https://conductscience.org/library/papers/33811777PubMed
832766815Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study.Clin Infect Dis2021https://conductscience.org/library/papers/32766815PubMed
932881315COVID-19 in lung transplant recipients: A single center case series from New York City.Am J Transplant2020https://conductscience.org/library/papers/32881315PubMed
1033148977COVID-19 and Solid Organ Transplantation: A Review Article.Transplantation2021https://conductscience.org/library/papers/33148977PubMed
1133051358Impact of comorbidities on clinical prognosis in 1280 patients with different types of COVID-19.J Investig Med2021https://conductscience.org/library/papers/33051358PubMed
1215130908Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.Am J Respir Crit Care Med2004https://conductscience.org/library/papers/15130908PubMed
1334709680COVID-19 in lung transplant recipients: an overview of the Swedish national experience.Transpl Int2021https://conductscience.org/library/papers/34709680PubMed
1432780300Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.CNS Drugs2020https://conductscience.org/library/papers/32780300PubMed
1532961245Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney Injury.Am J Kidney Dis2021https://conductscience.org/library/papers/32961245PubMed
1635368985One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience.Transplant Direct2022https://conductscience.org/library/papers/35368985PubMed
1733969180First COVID-19 Vaccines Receiving the US FDA and EMA Emergency Use Authorization.Discoveries (Craiova)2021https://conductscience.org/library/papers/33969180PubMed
1833089648COVID-19 in lung transplant recipients: A multicenter study.Am J Transplant2021https://conductscience.org/library/papers/33089648PubMed
1921521473Respiratory viruses in lung transplant recipients: a critical review and pooled analysis of clinical studies.Am J Transplant2011https://conductscience.org/library/papers/21521473PubMed
2034018307Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis.Diabetes Metab Res Rev2022https://conductscience.org/library/papers/34018307PubMed

See all 24 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40469640

GET https://conductscience.org/api/papers/v1/40469640/references?page=2